Stock prices for chemical manufacturer Bayer dropped sharply Tuesday morning following uncertainty from the U.S. Supreme Court regarding the company’s legal battle over its popular Roundup herbicide.
The German-based company’s shares plummeted as much as 6.5% during early trading, settling at a 3.2% decline by 7:31 GMT.
During Monday’s Supreme Court session, justices seemed uncertain about Bayer’s request to dismiss thousands of legal claims alleging the corporation failed to properly alert consumers that Roundup’s main chemical component may lead to cancer development.
The chemical giant’s stock performance has struggled throughout April, losing nearly 7% of its market value this month and heading toward its third straight month of declining prices.
